Lantern Pharma CEO Panna Sharma to Discuss AI Platform on Bloomberg TV

Summary

Lantern Pharma Inc. will be featured in an interview on the RedChip Small Stocks, Big Money™ show airing on Bloomberg TV on July 26 at 7 p.m. ET. CEO Panna Sharma will discuss the company’s innovative AI platform, RADR®, and its clinical-stage programs targeting high-need cancer indications. Lantern’s efficient model has enabled rapid development of oncology programs, positioning it as a leader in AI-driven precision oncology. The interview will be accessible to an estimated 73 million homes across the U.S. Acceswire

Impact Analysis

The event is classified at the company level as it involves Lantern Pharma’s CEO discussing strategic aspects of the company on Bloomberg TV. First-order effects include increased visibility and potential investor interest due to the wide reach of Bloomberg TV. It highlights Lantern’s innovative use of AI in oncology, potentially attracting interest from investors looking for opportunities in biotech and AI sectors. Second-order effects could involve heightened interest across the AI-driven healthcare sector, influencing peer companies and sparking discussions about AI in oncology. Investment opportunities may arise if market sentiment turns positive, leading to increased stock prices for Lantern Pharma or related sector ETFs. Risks could involve scrutiny on clinical-stage program success and competition in the precision oncology field.Acceswire